SMTL ID : 6rln.2 (1 other biounit)

Crystal structure of RIP1 kinase in complex with GSK3145095

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.87 Å

Oligo State

monomer

Ligands

1 x K8K: ~{N}-[(3~{S})-7,9-bis(fluoranyl)-2-oxidanylidene-1,3,4,5-tetrahydro-1-benzazepin-3-yl]-3-(phenylmethyl)-1~{H}-1,2,4-triazole-5-carboxamide(Non-covalent)

K8K.1: 17 residues within 4Å: Chain A: V.40, I.52, M.53, K.54, V.85, L.87, L.99, V.100, M.101, H.145, I.163, A.164, D.165, L.166, L.168, S.170, F.171 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:V.40, A:K.54, A:L.99, A:D.165, A:L.166, A:L.168 Hydrogen bonds: A:K.54, A:L.99, A:D.165 Water bridges: A:L.87

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Harris, P.A. et al., Identification of a RIP1 Kinase Inhibitor Clinical Candidate (GSK3145095) for the Treatment of Pancreatic Cancer. Acs Med.Chem.Lett. (2019)

Release Date

2019-07-03

Peptides

Receptor-interacting serine/threonine-protein kinase 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Receptor-interacting serine/threonine-protein kinase 1

Related Entries With Identical Sequence